ZENOTECH FILES SEVEN ABBREVIATED NEW DRUG APPLICATIONS (ANDA) IN US FOR GENERIC INJECTABLES

Search News

RANBAXY-promoted Zenotech has filed for seven abbreviated new drug application(ANDA) in the US for generic injectables. The market size for these products, currently catered by the innovator drug firms, is estimated at over $2 billion. In addition Hyderabad-based Zenotech is also in the process of filing 10 more ANDAs, five each in the areas of generic injectables and oncology products in 2008. When contacted Zenotech, managing director, Jayaram Chigurupati, said, "We expect to launch the products for the general injectables for which the ANDAs have been just filed by end of 2008 or by early 2009. Though there will be price erosion we expect to generate significant revenues from these launches." It takes anywhere between 1-2 year for companies to get marketing approval after an application for ANDA is filed.

Find Lawyer / Law Firm

Extradition Law in India

Every time an offender stealthily leaves India to take refuge in another country, the Government of India starts all over again with its strategy of bringing him back to the nation to make him stan More

Legal Consultation - Consult over phone, chat or send questions

Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion  More